HPHA — Heidelberg Pharma AG Cashflow Statement
0.000.00%
Last trade - 00:00
- €139.81m
- €102.21m
- €9.86m
2019 November 30th | 2020 November 30th | 2021 November 30th | 2022 November 30th | 2023 November 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -10.1 | -18.4 | -26.1 | -19.7 | -20.3 |
Depreciation | |||||
Non-Cash Items | 0.726 | 0.754 | 1.2 | 0.496 | -4.12 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.319 | -1.01 | -2.48 | 9.59 | -10.1 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -8.56 | -17.9 | -26.6 | -8.86 | -33.7 |
Capital Expenditures | -0.963 | -1.43 | -1.39 | -0.613 | -0.96 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -0.013 | 0.144 | -0.013 | 0.015 | 6.81 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -0.976 | -1.29 | -1.4 | -0.598 | 5.85 |
Financing Cash Flow Items | 0 | -0.061 | -0.749 | -0.818 | 0 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0 | 14.3 | 29.2 | 84 | -10.1 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -9.56 | -4.9 | 1.16 | 75.2 | -37.9 |